Serious adverse events reported in certolizumab-treated patients included tuberculosis (including reactivation of latent disease) and malignant diseases such as lymphoma.
Because cases of new and worsening congestive heart failure have been reported with certolizumab therapy, patients with heart failure should be treated with caution and monitored carefully.